1. Home
  2. CRIS vs AAME Comparison

CRIS vs AAME Comparison

Compare CRIS & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • AAME
  • Stock Information
  • Founded
  • CRIS 2000
  • AAME 1968
  • Country
  • CRIS United States
  • AAME United States
  • Employees
  • CRIS N/A
  • AAME N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • AAME Life Insurance
  • Sector
  • CRIS Health Care
  • AAME Finance
  • Exchange
  • CRIS Nasdaq
  • AAME Nasdaq
  • Market Cap
  • CRIS 22.9M
  • AAME 68.4M
  • IPO Year
  • CRIS 2000
  • AAME N/A
  • Fundamental
  • Price
  • CRIS $1.67
  • AAME $3.44
  • Analyst Decision
  • CRIS Strong Buy
  • AAME
  • Analyst Count
  • CRIS 2
  • AAME 0
  • Target Price
  • CRIS $16.50
  • AAME N/A
  • AVG Volume (30 Days)
  • CRIS 76.7K
  • AAME 38.7K
  • Earning Date
  • CRIS 11-13-2025
  • AAME 11-11-2025
  • Dividend Yield
  • CRIS N/A
  • AAME 0.59%
  • EPS Growth
  • CRIS N/A
  • AAME N/A
  • EPS
  • CRIS N/A
  • AAME 0.10
  • Revenue
  • CRIS $11,405,000.00
  • AAME $198,977,000.00
  • Revenue This Year
  • CRIS $1.41
  • AAME N/A
  • Revenue Next Year
  • CRIS $7.46
  • AAME N/A
  • P/E Ratio
  • CRIS N/A
  • AAME $32.42
  • Revenue Growth
  • CRIS 12.24
  • AAME 6.98
  • 52 Week Low
  • CRIS $1.02
  • AAME $1.25
  • 52 Week High
  • CRIS $6.44
  • AAME $3.71
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 45.61
  • AAME 66.93
  • Support Level
  • CRIS $1.63
  • AAME $3.20
  • Resistance Level
  • CRIS $1.95
  • AAME $3.35
  • Average True Range (ATR)
  • CRIS 0.15
  • AAME 0.20
  • MACD
  • CRIS 0.00
  • AAME -0.03
  • Stochastic Oscillator
  • CRIS 17.65
  • AAME 86.67

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

Share on Social Networks: